96. Crohn disease Clinical trials / Disease details

Clinical trials : 2,400 / Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01580670 (ClinicalTrials.gov)	March 2012	3/4/2012	Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease	Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of TA-650 in Pediatric Patients With Moderate to Severe Crohn's Disease	Pediatric Crohn's Disease	Drug: TA-650	Mitsubishi Tanabe Pharma Corporation	NULL	Completed	6 Years	17 Years	All	14	Phase 3	Japan
2	NCT00805766 (ClinicalTrials.gov)	December 2008	9/12/2008	Efficacy and Safety of Increased Dose of TA-650 (Infliximab) in Patients With Crohn's Disease (CD)	Clinical Study to Assess the Efficacy and Safety of Increased Dose of TA-650 in Patients With Crohn's Disease (CD)	Crohn's Disease	Drug: TA-650	Mitsubishi Tanabe Pharma Corporation	NULL	Completed	16 Years	75 Years	All	39	Phase 3	Japan